FDA Expands Indication of Moxifloxacin (Avelox) for PlagueFDA Expands Indication of Moxifloxacin (Avelox) for Plague

The antibiotic comes with a boxed warning about serious adverse events, but given the deadly nature of plague, "the benefit...outweighs these potential risks," the agency said. FDA Approvals
Source: Medscape Emergency Medicine Headlines - Category: Emergency Medicine Tags: Infectious Diseases News Alert Source Type: news